The World Heart Federation's vision for worldwide cardiovascular disease prevention

The Lancet

Volumn 386, Issue 9991, 2015, Pages 399-402

  Yusuf, Salim ^a   Wood, David ^b   Ralston, Johanna ^c   Reddy, K Srinath ^d  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c WORLD HEART FEDERATION   (Switzerland)

^d PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOKINASE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANIMAL PRODUCT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILDHOOD DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL PRACTICE; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; GENERAL PRACTITIONER; GOVERNMENT; GROSS NATIONAL PRODUCT; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; HYPERTENSION; INCIDENCE; INFECTION; INTERNAL MEDICINE; LIFESTYLE MODIFICATION; LOWEST INCOME GROUP; MEDICAL DOCUMENTATION; NON COMMUNICABLE DISEASE; NOTE; OBESITY; PHYSICAL ACTIVITY; POPULATION; POPULATION RESEARCH; PREMATURE MORTALITY; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; TOBACCO USE; WORLD HEALTH ORGANIZATION; CARDIOVASCULAR DISEASES; HEALTH; HEALTH PROMOTION; INTEGRATED HEALTH CARE SYSTEM; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; STATISTICS AND NUMERICAL DATA; TRENDS;

CARDIOVASCULAR DISEASES; DELIVERY OF HEALTH CARE, INTEGRATED; GLOBAL HEALTH; HEALTH PROMOTION; HUMANS; INTERNATIONAL AGENCIES; INTERNATIONAL COOPERATION;

EID: 84937969590     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60265-3     Document Type: Note

References (28)

1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 385 2015 117 171
2. JE Dalen, JS Alpert, RJ Goldberg, RS Weinstein The epidemic of the 20th century: coronary heart disease Am J Med 127 2014 807 812
3. ES Ford, UA Ajani, JB Croft et al. Explaining the decrease in US deaths from coronary disease, 1980-2000 N Engl J Med 356 2007 2388 2398
4. S Yusuf, S Reddy, S Ounpuu, S Anand Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 104 2001 2746 2753
5. World development indicators: Health systems 2014 The World Bank http://wdi.worldbank.org/table/2.15 (accessed Dec 12, 2014).
6. WHO World Health Statistics 2014 2014 World Health Organization Geneva
7. D Berger Corruption ruins the doctor-patient relationship in India BMJ 348 2014 g3169
8. MD Huffman, KD Rao, A Pichon-Riviere et al. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries PLoS One 6 2011 e20821
9. S Yusuf, S Rangarajan, K Teo the PURE Investigators Cardiovascular risk and events in 17 low-, middle-, and high-income countries N Engl J Med 371 2014 818 827
10. WHO Global action plan for the prevention and control of noncommunicable diseases 2013-2010 2013 World Health Organization Geneva
11. WHO 2014 global progress report on implementation of the WHO Framework Convention on Tobacco Control 2014 World Health Organization Geneva
12. CK Chow, KK Teo, S Rangarajan the PURE (Prospective Urban Rural Epidemiology) Study investigators Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries JAMA 310 2013 959 968
13. S Yusuf, A Attaran, J Bosch the Working Group on the Summit on Combination Therapy for CVD Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges Eur Heart J 35 2014 353 364
14. K Kotseva, D Wood, G De Backer et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Lancet 373 2009 929 940
15. Khatib R. Availability and affordability of medicines and their impact on use to prevent cardiovascular disease in high, middle, and low-income countries: results from the PURE study. PhD thesis, McMaster University, 2014.
16. DA Wood, K Kotseva, S Connolly the EUROACTION Study Group Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial Lancet 371 2008 1999 2012
17. DY Kamath, D Xavier, R Gupta et al. Rationale and design of a randomized controlled trial evaluating community health worker-based interventions for the secondary prevention of acute coronary syndromes in India (SPREAD) Am Heart J 168 2014 690 697
18. TA Gaziano, G Galea, KS Reddy Scaling up interventions for chronic disease prevention: the evidence Lancet 370 2007 1939 1946
19. C McGorrian, S Yusuf, S Islam the INTERHEART Investigators Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score Eur Heart J 32 2011 581 589
20. S Yusuf, S Hawken, S Ounpuu the INTERHEART Study Investigators Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Lancet 364 2004 937 952
21. MJ O'Donnell, D Xavier, L Liu the INTERSTROKE investigators Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study Lancet 376 2010 112 123
22. Z Chen, J Chen, R Collins the China Kadoorie Biobank collaborative group China Kadoorie Biobank of 0·5 million people: survey methods, baseline characteristics and long-term follow-up Int J Epidemiol 40 2011 1652 1666
23. H Tunstall-Pedoe, D Vanuzzo, M Hobbs et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations Lancet 355 2000 688 700
24. CM Lawes, A Rodgers, DA Bennett the Asia Pacific Cohort Studies Collaboration Blood pressure and cardiovascular disease in the Asia Pacific region J Hypertens 21 2003 707 716
25. Intersalt Cooperative Research Group Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion BMJ 297 1988 319 328
26. 2011 High level meeting on prevention and control of non-communicable diseases. Political declaration of the high-level meeting of the general assembly on the prevention and control of non-communicable diseases 2011 United Nations General Assembly New York (Document A/66/L.1) Available from: http://www.un.org/en/ga/ncdmeeting2011 (accessed Dec 11, 2014).
27. Huffman MD, Perel P, Beller GA. et al. World Heart Federation emerging leaders' program: an innovative capacity building program to facilitate "25 × 25". Global Heart (in press).
28. AE Moran, MH Forouzanfar, GA Roth et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study Circulation 129 2014 1483 1492